GSK plc (GSK) stock saw a decline, ending the day at $33.09 which represents a decrease of $-0.66 or -1.96% from the prior close of $33.75. The stock opened at $33.26 and touched a low of $33.01 ...
Ouro will leverage $120 million in funding to develop novel T cell engagers with potential to reset the immune system in patients with chronic immune-mediated ...
GSK plc has announced that the US Food and Drug Administration (USFDA) has accepted for review the regulatory application of ...
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...
In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...
TORONTO, ON / ACCESSWIRE / January 10, 2025 / Toggle3D.ai (the "Company") (OTCQB:TGGLF)(CSE:TGGL)(FSE:Q0C), a Nextech3d.ai ...
The US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix, GSK’s recombinant zoster vaccine for the prevention of ...
Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...
Hosted on MSN22h
Do TNF Inhibitors Really Worsen RA-Associated Lung Disease?Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...
Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback